Skip to content

Queer Quit: smoking cessation programme tailored to gay men

Queer Quit: a pilot study of a smoking cessation programme tailored to gay men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN36851118
Enrollment
75
Registered
2013-10-02
Start date
2009-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette smoking Mental and Behavioural Disorders

Interventions

We aim at a minimum of five groups with 15 participants each. The programme consists of seven weekly closed-group sessions, each lasting 2.5 hours. Sessions 1 and 2 of the programme have an education
What can you expect when you quit smoking? Minimise the side effects - NRTs and prescription medication
Contraindications for prescription medication
What about prescription medication and HIV anti-retroviral therapy? The issues of combination usage of NRT and prescription medication Week 2: Are you ready to stop smoking? Carbon monoxide and what i
Stop Smoking action plan
Smoking diary
Preparing for Quit Day Week 3: Quit Day
Quit Team Contact Sheet Week 4: Inexpensive holistic stop-smoking ideas Week 5: Weight gain issues Week 6: Your support network Week 7: Celebration

Sponsors

Federal Office of Public Health (FOPH) (Switzerland)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Smoking, gay men or men who have sex with men older than 18 years with strong intentions to quit

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
Seven-day point prevalence smoking abstinence six months following the last program session via the question: Have you smoked during the past seven days?

Secondary

MeasureTime frame
1. Depression [Beck Depression Inventory (BDI-V)] measured at baseline, session 7 and at the six-month follow-up 2. Anxiety [Beck Anxiety Inventory (BAI)] measured at baseline, session 7 and at the six-month follow-up 3. Mental and physical health [Short-Form Health Survey (SF-12)] measured at baseline, session 7 and at the six-months follow-up 4. Alcohol and drug use in the previous 30 days (European Addiction Severity Index)

Countries

Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 21, 2026